AEYE vs SOTK

AEYE exhibits severe financial health concerns, evidenced by a Piotroski F-Score of 1/9, indicating extreme weakness in operational and financial stability. The company operates at a significant loss with negative ROE (-43.22%) and ROA (-6.41%), while carrying a dangerously high debt-to-equity ratio of 2.75 and a current ratio below 1.0, signaling liquidity risk. Despite modest revenue growth (7.90% YoY), earnings volatility and a history of large negative earnings surprises undermine confidence. The stock trades at a premium valuation (Price/Sales: 1.76, Price/Book: 14.74) relative to its profitability and financial health, making it vulnerable to downward revisions. Analysts' strong_buy consensus appears disconnected from fundamental reality.

SOTK exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. The stock is currently trading at $4.18, a substantial premium over both its Graham Number ($1.66) and estimated Intrinsic Value ($2.94). While the company maintains a strong liquidity position with a current ratio of 4.24, negative year-over-year revenue growth (-3.60%) suggests a lack of organic expansion. The combination of bearish insider activity and a 0/100 technical trend further reinforces a negative outlook.